---
title: "Rentokil Initial plc Stock 12‑Month Price Target Cut to $35.28, Implies 24% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293811988.md"
description: "Analysts have lowered Rentokil Initial plc's 12-month average price target from $35.50 to $35.28, implying a 24% upside based on the July 24 closing price. Forecasts range between $30.23 and $42.13. Despite the cut, the consensus rating remains 'Buy' among 16 covering analysts, with 11 buys, 5 holds, and no sells."
datetime: "2026-07-25T04:20:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293811988.md)
  - [en](https://longbridge.com/en/news/293811988.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293811988.md)
generator: "portal-rs"
---

# Rentokil Initial plc Stock 12‑Month Price Target Cut to $35.28, Implies 24% Upside

-   According to estimates from 14 analysts, Rentokil Initial plc stock's average price target has fallen from $35.5 to $35.28, with forecasts ranging from $30.23 to $42.13 per share
-   Based on the Jul. 24 closing price, the updated target implies approximately 24% potential upside
-   Consensus rating remains at “Buy” across 16 covering analysts, with 11 Buys, 5 Holds and 0 Sells

Explore more price target data and ratings for Rentokil Initial plc on the , and track all previous and future analyst recommendations for Rentokil Initial plc in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [RTO.US](https://longbridge.com/en/quote/RTO.US.md)
- [RTO.UK](https://longbridge.com/en/quote/RTO.UK.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Dimensional Fund Advisors LP Trims Stock Holdings in Rentokil Initial PLC $RTO](https://longbridge.com/en/news/295625994.md)
- [REG - Rentokil Initial PLC - Holding(s) in Company](https://longbridge.com/en/news/294798244.md)
- [Marvell Stock Sinks 35%, But Most Analysts Are Bullish on MRVL Ahead of Q2](https://longbridge.com/en/news/296260742.md)
- [TJX Companies' (TJX) "Buy" Rating Reiterated at BTIG Research](https://longbridge.com/en/news/296517269.md)
- [Analyst Reiterates Buy on ProMIS Neurosciences, Maintaining $35 Price Target Amid Strong Cash Position and PMN310 Clinical Progress](https://longbridge.com/en/news/296004030.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**